Patents by Inventor Dipayan SARKAR

Dipayan SARKAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12528777
    Abstract: Compounds having Structure I are provided for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I are capable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: January 20, 2026
    Assignee: Council of Scientific & Industrial Research
    Inventors: Arindam Talukdar, Partha Chakrabarti, Dipayan Sarkar, Saheli Chowdhury, Sunny Goon, Subrata Das, Nirmal Das, Dipika Sarkar
  • Publication number: 20250154112
    Abstract: The present invention described herein relates to a compound having Structure I for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I are capable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.
    Type: Application
    Filed: December 19, 2022
    Publication date: May 15, 2025
    Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN.
    Inventors: Arindam TALUKDAR, Partha CHAKRABARTI, Dipayan SARKAR, Saheli Kumar CHOWDHURY, Sunny GOON, Abhishek SEN, Uddipta GHOSH DASTIDAR, Binita PATRA, Israful HOQUE
  • Patent number: 12172991
    Abstract: The invention described herein relates to the compounds of Formula I for treating diseases and disorders for which inhibition or modulation of the topoisomerase I enzyme produces a physiologically beneficial response, in particular for the treatment of breast cancer. Also provided is the process of preparing compounds of Formula I.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: December 24, 2024
    Assignees: Council of Scientific & Industrial Research, Indian Association for the Cultivation of Science
    Inventors: Arindam Talukdar, Benu Brata Das, Biswajit Kundu, Subhendu K. Das, Chowdhuri Srijita Paul, Dipayan Sarkar, Sourav Pal, Debomita Bhattacharya, Ayan Mukherjee, Subhajit Roy
  • Publication number: 20240350574
    Abstract: Compositions comprising phenolic phytochemicals of oregano, cranberry, or Rhodiola are provided. Compositions comprising a polymer, clay, and the phenolic phytochemicals are also provided. Methods of using the phenolic phytochemical compositions to treat a subject with bone metastasis are also provided, particularly methods of treating bone metastasis from breast or prostate cancer.
    Type: Application
    Filed: April 19, 2024
    Publication date: October 24, 2024
    Inventors: KALPANA S. KATTI, DINESH RAMANATH KATTI, Kalidas Shetty, Dipayan Sarkar, Preetham Ravi
  • Publication number: 20230357165
    Abstract: Compounds having Structure I are provided for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I are capable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.
    Type: Application
    Filed: June 25, 2021
    Publication date: November 9, 2023
    Inventors: Arindam Talukdar, Partha Chakrabarti, Dipayan Sarkar, Saheli Chowdhury, Sunny Goon, Subrata Das, Nirmal Das, Dipika Sarkar
  • Publication number: 20210246128
    Abstract: The invention described herein relates to the compounds of Formula I for treating diseases and disorders for which inhibition or modulation of the topoisomerase I enzyme produces a physiologically beneficial response, in particular for the treatment of breast cancer. Also provided is the process of preparing compounds of Formula I.
    Type: Application
    Filed: May 24, 2019
    Publication date: August 12, 2021
    Inventors: Arindam TALUKDAR, Benu Brata DAS, Biswajit KUNDU, Subhendu K. DAS, Chowdhuri Srijita PAUL, Dipayan SARKAR, Sourav PAL, Debomita BHATTACHARYA, Ayan MUKHERJEE, Subhajit ROY